Transcarotid artery revascularization with a neuroprotection system was associated with a low rate of stroke in patients with carotid artery stenosis, according to 1-year results of the ROADSTER trial.
As Cardiology Today’s Intervention previously reported, transcarotid artery revascularization (TCAR) with a neuroprotection system (Enroute, Silk Road Medical) was associated with lower 30-day stroke and death rates compared with traditional carotid stenting
For the present analysis, researchers analyzed 165 patients (112 from pivotal phase; 53 from extended-access cohort; mean age, 74 years; 65% men; 80% asymptomatic) with carotid artery stenosis at high risk for endarterectomy.
According to the researchers, high-risk anatomic factors included 11% of patients with contralateral carotid artery occlusion, 1.8% with tandem stenosis greater than 70%, 25% with high cervical carotid artery stenosis, 25.6% with restenosis after carotid endarterectomy, 4.3% with bilateral stenosis requiring treatment and 14.6% with a hostile neck. In addition, some patients had high-risk cardiac factors, including 14% with coronary disease in two or more vessels and a history of angina.
Read More: https://www.healio.com/cardiac-vascular-intervention/cerebrovascular/news/online/%7bf2df72f5-1e66-4685-bf00-5eb0939230d4%7d/novel-transcarotid-device-yields-low-stroke-rate-during-carotid-artery-stenting
Comments are closed.